Review



mouse monoclonal antibody against human st2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    R&D Systems mouse monoclonal antibody against human st2
    Figure 1. Corticosteroid treatment increases serum levels of <t>ST2</t> in UC. Serum ST2 levels in UC patients grouped according to therapies (A) or according to disease score activity and corticosteroid (CORT) treatment (B) were determined by ELISA. 5-ASA (5-aminosalicylic acid), AZA (azathioprine), corticosteroids (hydrocortisone, prednisone and prednisolone), IFX (infliximab). Differences were assessed using the Kruskal- Wallis test and Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001. sST2 (C), IL6 (D) in conditional media of biopsies from healthy controls (HC) or UC patients, stimulated or not with 100 nM Dexametasone (Dex) for 24 hours. Differences between medians were assessed using the Mann-Whitney U-test. *p < 0.05; **p < 0.01.
    Mouse Monoclonal Antibody Against Human St2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+human+st2/Human+ST2%2FIL-33R+Antibody/pm28860510-254-1-8
    Average 92 stars, based on 10 article reviews
    mouse monoclonal antibody against human st2 - by Bioz Stars, 2026-09
    92/100 stars

    Images

    1) Product Images from "A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis."

    Article Title: A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis.

    Journal: Scientific reports

    doi: 10.1038/s41598-017-10465-0

    Figure 1. Corticosteroid treatment increases serum levels of ST2 in UC. Serum ST2 levels in UC patients grouped according to therapies (A) or according to disease score activity and corticosteroid (CORT) treatment (B) were determined by ELISA. 5-ASA (5-aminosalicylic acid), AZA (azathioprine), corticosteroids (hydrocortisone, prednisone and prednisolone), IFX (infliximab). Differences were assessed using the Kruskal- Wallis test and Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001. sST2 (C), IL6 (D) in conditional media of biopsies from healthy controls (HC) or UC patients, stimulated or not with 100 nM Dexametasone (Dex) for 24 hours. Differences between medians were assessed using the Mann-Whitney U-test. *p < 0.05; **p < 0.01.
    Figure Legend Snippet: Figure 1. Corticosteroid treatment increases serum levels of ST2 in UC. Serum ST2 levels in UC patients grouped according to therapies (A) or according to disease score activity and corticosteroid (CORT) treatment (B) were determined by ELISA. 5-ASA (5-aminosalicylic acid), AZA (azathioprine), corticosteroids (hydrocortisone, prednisone and prednisolone), IFX (infliximab). Differences were assessed using the Kruskal- Wallis test and Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001. sST2 (C), IL6 (D) in conditional media of biopsies from healthy controls (HC) or UC patients, stimulated or not with 100 nM Dexametasone (Dex) for 24 hours. Differences between medians were assessed using the Mann-Whitney U-test. *p < 0.05; **p < 0.01.

    Techniques Used: Activity Assay, Enzyme-linked Immunosorbent Assay, Comparison, MANN-WHITNEY

    Figure 4. Corticosteroid treatment increases sST2 levels in UC patients with IL1RL1 genetic variants. Serum ST2 levels determined by ELISA in genotyped UC patients (A), controls and (B) UC patients receiving or not receiving corticosteroids (C). Kruskal-Wallis test with Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001.
    Figure Legend Snippet: Figure 4. Corticosteroid treatment increases sST2 levels in UC patients with IL1RL1 genetic variants. Serum ST2 levels determined by ELISA in genotyped UC patients (A), controls and (B) UC patients receiving or not receiving corticosteroids (C). Kruskal-Wallis test with Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001.

    Techniques Used: Enzyme-linked Immunosorbent Assay, Comparison

    Related Articles

    Binding Assay:

    Article Title: Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
    Article Snippet: .. Non-specific binding was blocked and samples were incubated with a mouse monoclonal antibody against human ST2 (MAB523, R&D Systems) followed by an Alexa 546-tagged secondary goat antibody against mouse IgG (Invitrogen/Life Technologies, Carlsbad, CA, USA) to detect ST2. .. Cell nuclei were stained using Hoechst 33342 (Thermo/Life Technologies, Carlsbad, CA, USA).

    Incubation:

    Article Title: Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
    Article Snippet: .. Non-specific binding was blocked and samples were incubated with a mouse monoclonal antibody against human ST2 (MAB523, R&D Systems) followed by an Alexa 546-tagged secondary goat antibody against mouse IgG (Invitrogen/Life Technologies, Carlsbad, CA, USA) to detect ST2. .. Cell nuclei were stained using Hoechst 33342 (Thermo/Life Technologies, Carlsbad, CA, USA).



    Similar Products

    mouse monoclonal antibody against human st2  (R&D Systems)
    92
    R&D Systems mouse monoclonal antibody against human st2
    Figure 1. Corticosteroid treatment increases serum levels of <t>ST2</t> in UC. Serum ST2 levels in UC patients grouped according to therapies (A) or according to disease score activity and corticosteroid (CORT) treatment (B) were determined by ELISA. 5-ASA (5-aminosalicylic acid), AZA (azathioprine), corticosteroids (hydrocortisone, prednisone and prednisolone), IFX (infliximab). Differences were assessed using the Kruskal- Wallis test and Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001. sST2 (C), IL6 (D) in conditional media of biopsies from healthy controls (HC) or UC patients, stimulated or not with 100 nM Dexametasone (Dex) for 24 hours. Differences between medians were assessed using the Mann-Whitney U-test. *p < 0.05; **p < 0.01.
    Mouse Monoclonal Antibody Against Human St2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+antibody+against+human+st2/Human+ST2%2FIL-33R+Antibody/pm28860510-254-1-8
    Average 92 stars, based on 1 article reviews
    mouse monoclonal antibody against human st2 - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1. Corticosteroid treatment increases serum levels of ST2 in UC. Serum ST2 levels in UC patients grouped according to therapies (A) or according to disease score activity and corticosteroid (CORT) treatment (B) were determined by ELISA. 5-ASA (5-aminosalicylic acid), AZA (azathioprine), corticosteroids (hydrocortisone, prednisone and prednisolone), IFX (infliximab). Differences were assessed using the Kruskal- Wallis test and Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001. sST2 (C), IL6 (D) in conditional media of biopsies from healthy controls (HC) or UC patients, stimulated or not with 100 nM Dexametasone (Dex) for 24 hours. Differences between medians were assessed using the Mann-Whitney U-test. *p < 0.05; **p < 0.01.

    Journal: Scientific reports

    Article Title: A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis.

    doi: 10.1038/s41598-017-10465-0

    Figure Lengend Snippet: Figure 1. Corticosteroid treatment increases serum levels of ST2 in UC. Serum ST2 levels in UC patients grouped according to therapies (A) or according to disease score activity and corticosteroid (CORT) treatment (B) were determined by ELISA. 5-ASA (5-aminosalicylic acid), AZA (azathioprine), corticosteroids (hydrocortisone, prednisone and prednisolone), IFX (infliximab). Differences were assessed using the Kruskal- Wallis test and Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001. sST2 (C), IL6 (D) in conditional media of biopsies from healthy controls (HC) or UC patients, stimulated or not with 100 nM Dexametasone (Dex) for 24 hours. Differences between medians were assessed using the Mann-Whitney U-test. *p < 0.05; **p < 0.01.

    Article Snippet: A mouse monoclonal antibody against human ST2 (MAB523, R&D Systems) and an Alexa 546-tagged secondary goat antibody against mouse IgG (Invitrogen/Life Technologies, Carlsbad, CA, USA) were used.

    Techniques: Activity Assay, Enzyme-linked Immunosorbent Assay, Comparison, MANN-WHITNEY

    Figure 4. Corticosteroid treatment increases sST2 levels in UC patients with IL1RL1 genetic variants. Serum ST2 levels determined by ELISA in genotyped UC patients (A), controls and (B) UC patients receiving or not receiving corticosteroids (C). Kruskal-Wallis test with Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001.

    Journal: Scientific reports

    Article Title: A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis.

    doi: 10.1038/s41598-017-10465-0

    Figure Lengend Snippet: Figure 4. Corticosteroid treatment increases sST2 levels in UC patients with IL1RL1 genetic variants. Serum ST2 levels determined by ELISA in genotyped UC patients (A), controls and (B) UC patients receiving or not receiving corticosteroids (C). Kruskal-Wallis test with Dunn’s multiple comparison post-test. *p < 0.05; **p < 0.01; ***p < 0.001.

    Article Snippet: A mouse monoclonal antibody against human ST2 (MAB523, R&D Systems) and an Alexa 546-tagged secondary goat antibody against mouse IgG (Invitrogen/Life Technologies, Carlsbad, CA, USA) were used.

    Techniques: Enzyme-linked Immunosorbent Assay, Comparison